REVYVE
Live / Registered — Registered (as of 08 Apr 2025)
What this means for you
Registered since 08 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98106841
- Registration number
- 7755802
- Mark type
- Stylized text
- Filed
- 28 Jul 2023
- Published for opposition
- 18 Jun 2024
- Registered
- 08 Apr 2025
- Attorney of record
- C. Brandon Browning
Goods and services
- Class 005 — Pharmaceuticals: Topical antimicrobial preparations for inhibiting bacteria in wounds; Antimicrobials for dermatologic use, namely, antimicrobial wound gels; Antimicrobials for dermatologic use, namely, topical preparations for treating diabetic foot ulcers, leg ulcers, pressure ulcers, first- and second-degree burns, partial- and full-thickness wounds, large surface area wounds, and surgical incisions; none of the foregoing for treating acne
Owner
- Kane Biotech Inc., Winnipeg, Manitoba, CA
- Kane Biotech Inc., Winnipeg, Manitoba, CA
- Kane Biotech Inc., Winnipeg, Manitoba, CA
Prosecution history
- 08 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Jan 2025 — USE AMENDMENT FILED
- 18 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2024 — PUBLISHED FOR OPPOSITION
- 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 May 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE